SlateStone Wealth’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.2K Buy
+10,000
New +$31.9K ﹤0.01% 281

Other funds holding NAGE

SlateStone Wealth's NAGE Position: Q3 2026 in Review

SlateStone Wealth opened a new position in Niagen Bioscience (NAGE) in Q3 2026: 10,000 shares worth $29.2K. The stake represents ﹤0.01% of the portfolio and ranks #281 among its holdings.

123 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.

  • SlateStone Wealth held 10,000 shares of Niagen Bioscience worth $29.2K as of Q3 2026.
  • Niagen Bioscience was a new SlateStone Wealth position in Q3 2026.
  • Niagen Bioscience made up ﹤0.01% of SlateStone Wealth's portfolio in Q3 2026, its #281 holding.
  • 123 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.

Based on SlateStone Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.